Search Grantees

Abstract or Project Description

Abstract or Project Description

To help maintain the take home book program for 174 classrooms and 3,383 children. Launch the program in 8 new classrooms supporting 132 children and their families. Through technical assistance visits, and workshops, Tandem will serve 261 educators at school sites.

Abstract or Project Description

The Bread Project offers culinary job training and placement services to those encountering employment obstacles like low income or lack of education. They provide hands-on training, assistance with job placement and collaborate with local businesses to address systemic employment barriers and foster economic independence.

Abstract or Project Description

Charlotte Maxwell Clinic is a 30-year-old nonprofit providing complementary, integrative therapies to low-income and underserved women with cancer.

Abstract or Project Description

The Oakland ChildrenÕs Initiative (Measure AA) is a 2018 Charter Amendment passed by the citizens of Oakland to deepen the city’s early investment in children and support them through college graduation.

Abstract or Project Description

The Lab provides substantial resources to support artists from underrepresented backgrounds, aiming to foster meaningful connections with communities whose voices have been marginalized. Through this commitment, The Lab serves as a catalyst for innovative artistic exploration and societal transformation.

Abstract or Project Description

For a planning grant to develop the Men of Color Early Education Teaching Fellows Pilot. The Unity Council, OUSD’s Office of Equity and Office of Early Childhood Education will plan this collaborative effort where they will investigate similar models, convene stakeholders in Oakland, and design a pilot that will leverage the SEEDS of  Learning model of providing a well-trained tutor to support classroom literacy instruction.

Abstract or Project Description

The Teaching Well’s mission is to stabilize schools by equipping educators with the resiliency and socio-emotional skills to communicate and collaborate more effectively.

Abstract or Project Description

Thetis is developing TP-317 as a safe, oral therapy for ulcerative colitis patients whose disease is incompletely controlled by first-line therapy that would be an alternative to aggressive immuno-suppressive therapies. TP-317 is a novel derivative of Resolvin-E1, a molecule that is produced naturally by the body to regulate inflammation and promote healing. By delivering Resolvin-E1 to the colon, TP-317 is expected to activate the body’s innate ability to resolve inflammation and repair damaged tissue. TP-317 has demonstrated significant therapeutic potential in animal models of IBD. The proposed project will support the development of a prototype pill that targets TP-317 delivery to the colon, a critical milestone for advancing TP-317 into clinical investigation. Aim-#1 includes TP-317 API synthesis, stability testing and characterization. Aim-#2 includes formulation feasibility studies and prototype tablet development. Aim-#3 characterizes the release profile of the prototype.

Abstract or Project Description

Immunosuppressive drugs and anti-inflammatory biologics are used to treat moderate-to-severe ulcerative colitis. Unfortunately, many patients suffer untoward effects, do not achieve remission and/or eventually relapse. Using a mouse model of colitis triggered by a pathogen of mice, we identified the host surface molecule B7-H3 as a suppressor of colonic inflammation. B7-H3 is thought to dampen the immune response to antigens, including microbial antigens, by suppressing the proliferation of ‘pathogenic lymphocytes’ that drive disease. We postulate that a weakened B7-H3 pathway contributes to ulcerative colitis. We will test the concept that stimulating the B7-H3 pathway suppresses colonic inflammation in mice and in humans. In mice, we will test whether treatment with recombinant B7-H3 protects the colon from inflammation and tissue damage elicited by a microbial pathogen. Using colonic biopsies obtained from patients with ulcerative colitis, we will test whether low B7-H3 expression is associated with high numbers of pathogenic lymphocytes and severe disease, and whether addition of recombinant B7-H3 blocks the proliferation of pathogenic lymphocytes. If successful, the proposed work will lay the foundation for additional studies aimed at optimizing the means to engage the B7-H3 pathway in ulcerative colitis.

Abstract or Project Description

By Bay Area playwright Philip Kan Gotanda. This play explores the challenges of and need to find solidarity in an age of growing polarization in American society.

Abstract or Project Description

United Roots believes in fostering supportive conditions that empower young people to create alternative, sustainable economies, envisioning their center as a gathering place for generations and cultures. Through youth leadership, they aim to cultivate a more peaceful, creative and equitable world, while also reintegrating urban communities with nature.

Abstract or Project Description

To support Unity Council’s Children & Family Services department in creating a set of strategic objectives that build on and improve program performance. This effort will also assess client outcomes and impacts, and provide recommendations to improve data capture, analysis, and action planning.

Abstract or Project Description

IBD patients have increased chances of developing colorectal cancer. Additionally this specific form of colon cancer is very difficult to treat. Despite numerous efforts we still do not fully understand the relationship between intestinal inflammation and the increased chance for colon cancer development. Understanding this will allow us to develop more specific and targeted prevention measures. Recently, a 3D culturing system of intestinal organoids (“”miniguts”” in a dish) has been developed. By clonally expanding single intestinal stem cells, we can obtain sufficient DNA to study DNA damage caused by or associated with chronic inflammation. The nature of this DNA damage will serve as a “”smoking gun”” that allows us to identify major forces causing IBD-associated colorectal cancer and thus to develop specific preventive therapies

Abstract or Project Description

Eicosanoids are signaling molecules that contribute to both the development and resolution of inflammation. Inflammasomes are immune sensors that help to trigger immune responses to infection. Tuft cells are specialized cells of the intestinal lining that are important during infection with parasitic worms. Eicosanoids and inflammasomes have been separately implicated in IBD, although the underlying mechanisms remain unclear. The role of tuft cells in IBD has not been studied. We hypothesize, based on results from our previous research, that tuft cells are a primary source of eicosanoids when inflammasomes are triggered in the intestinal lining. We plan to use specialized tools obtained or generated by our research groups to confirm this hypothesis and to assess how this unique convergence of tuft cells, inflammasomes, and eicosanoids might contribute to IBD. Drugs to modify the effects of eicosanoids are already available, thus our findings could have immediate clinical implications.

Abstract or Project Description

Although there are many drugs available for the treatment of IBD, most patients do not respond long-term to any one drug. One possible reason is that the condition we call “IBD” likely represents many distinct diseases, rather than simply just ulcerative colitis and Crohn’s disease, and each subtype may require a different treatment. Here we will address this problem by using a suite of state-of-the-art laboratory techniques that will allow us to study the genetic instructions (RNA) of thousands of individual cells sampled from the intestines of patients with IBD. Using bioinformatic methods, we will use this information to classify IBD into different diseases, which may help us to determine how best to treat each subtype. We also hope to discover new molecules that are involved in causing IBD, an important first step to developing new treatments for IBD

Abstract or Project Description

Inflammatory Bowel Disease (IBD) is characterized by chronic intestinal inflammation, which causes damage to the intestinal epithelium. This inflammatory response in the small and large bowel is thought to be initiated by interactions between genes, environment, and microbes, which reside in the gastrointestinal tract. However, the mechanisms by which environmental factors modulate susceptibility to IBD remain incompletely understood.

We hypothesize that changes in the host environment alters the susceptibility of intestinal tissues to damage, which is mediated by the microbes and the host immune response against them. Our preliminary data suggest that one such environmental factor is host metabolism, which regulates the expression of tissue tolerance programs to mitigate tissue damage caused during colitis. In this proposal, we will develop a new experimental framework to study intestinal tissue tolerance and identify the underlying mechanisms by which host metabolism protects tissues from microbe- and immune-mediated damage. A better understanding of these mechanisms will provide alternative targets and strategies for therapeutic intervention in IBD.

Abstract or Project Description

The gut is composed of many cell types that contribute to its complex functions and ability to adapt to changing conditions associated with diet, lifestyles and the environment. Each of these factors can affect the health of the gut and contribute to intestinal disease such as inflammatory bowel disease and intestinal discomfort and pain. Many current therapies target the immune system even though the gut contains many other types of cells which are crucial for sensing chemical changes within the gut. Our UCSF team of basic and clinical scientists is exploiting modern and powerful tools to revisit important but rare cell types within the gut that communicate with the nervous system. We are using these tools to ask if a novel pathway regulates the number and function of these critical cells. Such knowledge could be leveraged to generate therapies for intestinal disorders, particularly those associated with inflammatory pain.

Abstract or Project Description

Environmental factors are thought to contribute to the development of a range of human diseases, including inflammatory bowel disease (IBD) and autism spectrum disorder (ASD). Interestingly, the incidence of IBD is higher in patients with autism, compared to those without. We propose that inflammation to which a developing embryo may be exposed in the maternal womb, could be an environmental risk factor linking autism and IBD.

We previously showed that a particular type of immune cells, Th17 cells, in mothers, promotes autism-like phenotypes in offspring, using a mouse model of inflammation-induced neurodevelopmental disorders (i.e. autism). Th17 cells, and the pathways that control them, are also implicated in IBD. We propose that prenatal, maternal inflammation, through Th17 cells both enhances autistic phenotypes and increases IBD susceptibility in offspring. Our work thus aims to elucidate the intricate connection between maternal inflammation, autism and IBD. In addition, this research will lay the foundation for future studies to identify novel therapeutics for treating maternal inflammation- induced IBD.